ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $220,000 | -24.7% | 5,310 | +8.6% | 0.08% | -17.6% |
| Q2 2022 | $292,000 | -27.4% | 4,890 | -11.6% | 0.10% | -18.4% |
| Q1 2022 | $402,000 | -14.1% | 5,530 | -0.7% | 0.12% | +2.5% |
| Q4 2021 | $468,000 | +0.2% | 5,570 | +7.5% | 0.12% | -3.9% |
| Q3 2021 | $467,000 | -27.8% | 5,180 | -23.7% | 0.13% | -30.6% |
| Q2 2021 | $647,000 | -18.3% | 6,790 | -2.4% | 0.18% | -24.7% |
| Q1 2021 | $792,000 | -21.3% | 6,960 | -4.3% | 0.24% | -23.1% |
| Q4 2020 | $1,006,000 | +50.4% | 7,270 | -10.7% | 0.32% | +28.5% |
| Q3 2020 | $669,000 | +5.2% | 8,140 | +0.1% | 0.25% | -2.4% |
| Q2 2020 | $636,000 | – | 8,130 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |